Skip to search formSkip to main contentSkip to account menu

CABIN1 protein, human

Known as: CAIN, calcineurin inhibitor protein, human, Calcineurin Binding Protein Cabin 1 
Calcineurin-binding protein cabin-1 (2220 aa, ~246 kDa) is encoded by the human CABIN1 gene. This protein may be involved in both calcineurin binding… 
National Institutes of Health

Related topics

Related topics

11 relations

Broader (2)

Adaptor Proteins, Signal TransducingCalcineurin inhibitor
CABIN1 geneCABIN1 wt AlleleCell NucleusChromatin Structural Process

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Effect of Sirolimus on Calcineurin Inhibitor-Induced Nephrotoxicity Using Renal Expression of KLOTHO, an Antiaging Gene
Background. The aim of this study was to observe the effect of sirolimus (SRL) on calcineurin inhibitor (CNI)-induced… 
2010
2010
Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective…
2009
2009
Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Review
2008
Review
2008
Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Purpose of reviewGraft loss after first year of transplantation can be due to composite of factors that may include immunological… 
2007
2007
Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation
Abstract:  Small uncontrolled series have suggested that sirolimus favorably impacts renal function after orthotopic liver… 
2007
2007
Caspase-dependent apoptosis induced by calcineurin inhibitors was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical cells
Highly Cited
2006
Highly Cited
2006
Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
BACKGROUND Conversion from calcineurin inhibitor to sirolimus, rapamycin has become an option in patients with chronic allograft… 
2004
2004
Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure.
2003
2003
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity.
1956
1956
THE MECHANISM OF NILE BLUE STAINING OF LIPOFUSCINS
In 1908 J. L. Smith (23) reported simultaneous blue staining of fatty acids and red staining of neutral fats by aqueous solutions… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)